Midodrine as adjunctive support for treatment of refractory hypotension in the intensive care unit: A multicenter, randomized, placebo controlled trial (the MIDAS trial)

Midodrine as adjunctive support for treatment of refractory hypotension in the intensive care unit: A multicenter, randomized, placebo controlled trial (the MIDAS trial)

© 2017 The Author(s).Background: Patients admitted to intensive care units (ICU) are often treated with intravenous (IV) vasopressors. Persistent hypotension and dependence on IV vasopressors in otherwise resuscitated patients lead to delay in discharge from ICU. Midodrine is an oral alpha-1 adrener...

Full description

Bibliographic Details
Main Authors: Anstey, Matthew, Wibrow, B., Thevathasan, T., Roberts, B., Chhangani, K., Ng, P., Levine, A., DiBiasio, A., Sarge, T., Eikermann, M.
Format: Journal Article
Published: 2017
Online Access:http://hdl.handle.net/20.500.11937/52870

Internet

http://hdl.handle.net/20.500.11937/52870

Similar Items